::*''Merck KGaA v. Integra Lifesciences I, Ltd.'', limiting patent rights by allowing the use of patented compounds in preclinical studies as long as there is a reasonable basis for believing that the experiments will produce "the types of information that are relevant to an IND or NDA" in drug applications to the FDA. | ::*''Merck KGaA v. Integra Lifesciences I, Ltd.'', limiting patent rights by allowing the use of patented compounds in preclinical studies as long as there is a reasonable basis for believing that the experiments will produce "the types of information that are relevant to an IND or NDA" in drug applications to the FDA. |